CELL-FACTORY

Scaling up from a cell culture flask to a cell factory is a vital step in bridging laboratory research and industrial production. By adopting the right culture systems, laboratories and manufacturers can achieve efficient, reproducible, and large-scale cell expansion.

For adherent stem cell types, the cell factory, particularly the Multilayer Cell Factory, has become a widely adopted solution for expanding cell numbers while maintaining controlled culture conditions. However, alongside its advantages, the use of multilayer systems also presents specific technical and process-related challenges that must be carefully addressed.

Quality control is fundamental to the reliable production of cell culture consumables. From raw material qualification and precision manufacturing to surface treatment validation and batch traceability, each stage of the production process contributes to the performance and consistency of culture vessels.

Maintaining healthy HEK293 cells is essential for ensuring reliable results in protein expression, viral vector production, transfection workflows, and early-stage bioprocess development. This guide summarizes the key indicators researchers should monitor—covering cell morphology, metabolic activity, and contamination risks—to help build a stable and reproducible HEK293 culture system.

Cell factory has its material selection directly affecting the quality and efficiency of cell culture. This multilayer culture system imposes extremely strict requirements on raw materials, which must simultaneously meet multiple key indicators to ensure cells grow and proliferate in an optimal environment.

From vaccine manufacturing to gene therapy vector production, cell factories are driving cell culture from laboratory scale toward true industrialization. Within this transition, seeding density often serves as the first critical checkpoint for success.

The double-port design of the cell factory, with its advantages in improving operational efficiency, reducing bubble generation, promoting gas exchange, and supporting high-density culture, has become a leader in the field of cell culture. It provides more convenient and efficient solutions for scientific research and the production of biological products.

As gene therapy continues to expand from clinical trials to commercial-scale manufacturing, cell factory systems will remain an essential component of efficient, safe, and standardized viral vector production.

This article provides a structured comparison of HEK293 and CHO cells, focusing on use cases, metabolic behavior, protein modification capabilities, and culture systems, to help teams make informed decisions when selecting a cell platform.